| Application no. and date | 18702299.1 (espacenet) (Federated) (European Patent Register), 20180202 | | Patent/reg. no. and date | DK/EP 3576740, 20230614 | | Publication date | 20191211 | | Priority no. and date | US 201762455211 P, 20170206, EP 17209098, 20171220 | | EP pub. no. and date |
EP 3576740 20191211 | | Effective date | | | Applicant/owner | Janssen Pharmaceutica NV, Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | BB220752EPDK | | Inventor | STUYCKENS, Kim, c/o Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse, BE,
DE PORRE, Peter, Marie, Z., c/o Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse, BE,
SIEFKER-RADTKE, Arlene, O., c/o Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse, BE,
AVADHANI, Anjali, Narayan, c/o Janssen Pharmaceuticals Inc.
Springhouse Campus
1400 McKean Road
Springhouse
Pennsylvania 19477, US,
LORIOT, Yohann, c/o Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex, FR,
PEREZ RUIXO, Juan, Jose, c/o Janssen-Cilag, S.A.
Edificio Johnson & Johnson
Paseo de las Doce Estrellas, 5-7, 5° planta
Campo de las Naciones
28042 Madrid, ES | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 31/498 (2006.01) , A61P 35/00 (2006.01) , G01N 33/574 (2006.01) | | Title | CANCERBEHANDLING | | Int. application no. | EP2018052694 | | Int. publication no. | WO2018141921 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
